Loading...

Welby Inc.

4438.TJPX
Healthcare
Medical - Healthcare Information Services
¥279.00
¥-7.00(-2.45%)
Japanese Market opens in 12h 49m

Welby Inc. Fundamental Analysis

Welby Inc. (4438.T) shows moderate financial fundamentals with a PE ratio of -4.47, profit margin of -81.00%, and ROE of -1.49%. The company generates $0.6B in annual revenue with strong year-over-year growth of 20.39%.

Key Strengths

Cash Position21.98%
PEG Ratio-0.09
Current Ratio2.06

Areas of Concern

ROE-1.49%
Operating Margin-69.21%
We analyze 4438.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -179.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-179.3/100

We analyze 4438.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

4438.T struggles to generate sufficient returns from assets.

ROA > 10%
-62.01%

Valuation Score

Excellent

4438.T trades at attractive valuation levels.

PE < 25
-4.47
PEG Ratio < 2
-0.09

Growth Score

Excellent

4438.T delivers strong and consistent growth momentum.

Revenue Growth > 5%
20.39%
EPS Growth > 10%
33.82%

Financial Health Score

Moderate

4438.T shows balanced financial health with some risks.

Debt/Equity < 1
2.98
Current Ratio > 1
2.06

Profitability Score

Weak

4438.T struggles to sustain strong margins.

ROE > 15%
-148.59%
Net Margin ≥ 15%
-81.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is 4438.T Expensive or Cheap?

P/E Ratio

4438.T trades at -4.47 times earnings. This suggests potential undervaluation.

-4.47

PEG Ratio

When adjusting for growth, 4438.T's PEG of -0.09 indicates potential undervaluation.

-0.09

Price to Book

The market values Welby Inc. at 12.98 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

12.98

EV/EBITDA

Enterprise value stands at -5.71 times EBITDA. This is generally considered low.

-5.71

How Well Does 4438.T Make Money?

Net Profit Margin

For every $100 in sales, Welby Inc. keeps $-81.00 as profit after all expenses.

-81.00%

Operating Margin

Core operations generate -69.21 in profit for every $100 in revenue, before interest and taxes.

-69.21%

ROE

Management delivers $-1.49 in profit for every $100 of shareholder equity.

-1.49%

ROA

Welby Inc. generates $-62.01 in profit for every $100 in assets, demonstrating efficient asset deployment.

-62.01%

Following the Money - Real Cash Generation

Operating Cash Flow

Welby Inc. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Welby Inc. generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

4438.T converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.47

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.09

vs 25 benchmark

P/B Ratio

Price to book value ratio

12.98

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.60

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

2.98

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.06

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.49

vs 25 benchmark

ROA

Return on assets percentage

-0.62

vs 25 benchmark

ROCE

Return on capital employed

-0.84

vs 25 benchmark

How 4438.T Stacks Against Its Sector Peers

Metric4438.T ValueSector AveragePerformance
P/E Ratio-4.4728.92 Better (Cheaper)
ROE-148.59%747.00% Weak
Net Margin-81.00%-49468.00% (disorted) Weak
Debt/Equity2.980.40 Weak (High Leverage)
Current Ratio2.064.13 Strong Liquidity
ROA-62.01%-19478.00% (disorted) Weak

4438.T outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Welby Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-30.57%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-44.34%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-180.38%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ